GLYcoDiag
![]() |
||
GLYcoDiag es una empresa de investigación y desarrollo especializada en glicociencias que ofrece servicios y productos para los campos de la salud (biomarcadores, glicoproteínas recombinantes terapéuticas, vacunas), la cosmética (principios activos, diseño y mecanismos de "glicoactivos") y el medio ambiente (biopelículas, aguas residuales).
Desde 2015, GLYcoDiag desarrolla su propia gama de reactivos y kits para usos de investigación:
Lectinas naturales y recombinantes
Neoglicoproteínas y neoglicoclusters
Geles LEctPROFILE®, geles CarbPROFILE Kits LEctPROFILE® (kits basados en lectinas destinados al cribado / comparación / detección de ligandos) Página web: www.glycodiag.com
|
![Sambucus nigra Lectin (SNA/EBL I+II)](https://www.clinisciences.com/es/upload/thumbs/sambucus-nigra-elderberry-lectin-ukeftc-17c6fd.jpg)
Sambucus nigra Lectin (SNA/EBL I+II)
Sambucus nigra lectin (EBL I+II, also known as SNA) is isolated from elderberry bark. This lectin has a molecular weight of 140 kDa and is composed of two ricin-related lectins. EBL I+II is a tetrameric glycoprotein with a recognition of the Neu5Ac(alpha2-6)Gal or GalNAc linkage in glycoconjugates.
EBL I+II is not blood group specific but it does agglutinate type A erythrocytes more strongly than either B or O cells. Trypsin treated erythrocytes react better than untreated cells. Neuraminidase treated erythrocytes react with this lectin due to the presence of terminal galactose resides.
EBL I is composed of an A-chain with enzymatic activity and a B-chain with carbohydrate-binding activity. EBL II consists only of carbohydrate-binding B-chains. EBL I+II induces caspase-dependent apoptosis at low concentrations (nM) order, leading to typical symptoms of cell death in sensitive cells. This effect seems independent from the catalytic activity of the A-chain, but depends on the carbohydrate binding B-chain.
Resultados de su búsqueda : 3 Producto encontrado
Refine su búsqueda :
RUOCE / IVD
- Lectins
Referencia
Descripción
Cond.
Precio Sin IVA
‹
›